{"id":"https://openalex.org/W1990318506","doi":"https://doi.org/10.1158/1538-7445.tumimm2012-ia18","title":"Abstract IA18: T cell adoptive therapy for cancer: Translating the science.","display_name":"Abstract IA18: T cell adoptive therapy for cancer: Translating the science.","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W1990318506","doi":"https://doi.org/10.1158/1538-7445.tumimm2012-ia18","mag":"1990318506"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.tumimm2012-ia18","doi":"https://doi.org/10.1158/1538-7445.tumimm2012-ia18","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.tumimm2012-ia18","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055074037","display_name":"James Chih\u2010Hsin Yang","orcid":"https://orcid.org/0000-0002-5586-5138","observed_orcids":["https://orcid.org/0000-0002-5586-5138"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"James C. Yang","raw_affiliation_strings":["National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5055074037"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"1_Supplement","first_page":"IA18","last_page":"IA18"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.8241999745368958,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.8241999745368958,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.06129999831318855,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.060600001364946365,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.8100000023841858},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.9750000238418579},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.984000027179718},{"id":"https://openalex.org/keywords/total-body-irradiation","display_name":"total body irradiation","score":0.9909999966621399},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.7699999809265137},{"id":"https://openalex.org/keywords/t-cell-receptor-gene-transfer","display_name":"T cell receptor gene transfer","score":0.6890000104904175},{"id":"https://openalex.org/keywords/melan-a","display_name":"Melan-A","score":0.5830000042915344},{"id":"https://openalex.org/keywords/gp100","display_name":"gp100","score":0.9589999914169312},{"id":"https://openalex.org/keywords/tumor-specific-mutations","display_name":"tumor-specific mutations","score":0.41200000047683716},{"id":"https://openalex.org/keywords/long-term-survival","display_name":"long-term survival","score":0.4390000104904175},{"id":"https://openalex.org/keywords/clinical-translation","display_name":"clinical translation","score":0.3540000021457672},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.32600000500679016}],"concepts":[{"id":"https://openalex.org/C90375314","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive cell transfer","level":4,"score":0.7280179262161255},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6354462504386902},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.5687767267227173},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5417843461036682},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5286831259727478},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5276495218276978},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5225053429603577},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5162594318389893},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5071136951446533},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.47532039880752563},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3224274516105652},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28455328941345215},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.tumimm2012-ia18","doi":"https://doi.org/10.1158/1538-7445.tumimm2012-ia18","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.tumimm2012-ia18","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2074788814","https://openalex.org/W2098175570","https://openalex.org/W4309161029","https://openalex.org/W1990794592","https://openalex.org/W2564540600","https://openalex.org/W2565749953","https://openalex.org/W2335889039","https://openalex.org/W2150145041","https://openalex.org/W2022960657","https://openalex.org/W7056410703"],"abstract_inverted_index":{"Abstract":[0],"A":[1,571,612],"variety":[2,648],"of":[3,23,37,70,142,175,195,200,236,259,295,340,441,451,511,538,567,614,618,633,646,649,671],"immunizations,":[4],"cytokines":[5],"and":[6,33,43,59,81,145,178,205,255,335,376,480,541,560,580,624,683],"immune":[7],"checkpoint":[8],"inhibitors":[9],"have":[10,130,170,189,241,307,385,409,468,594],"been":[11,52,190,400,469],"used":[12],"in":[13,41,72,79,125,250,278,299,338,391,485,501,507,522,553,557,652],"the":[14,68,100,106,120,209,223,237,256,266,279,356,416,439,463,492,508,564,627,643,666,672],"effort":[15],"to":[16,31,47,55,94,97,306,321,432,436,462,514,526,530,546,641],"marshal":[17],"an":[18],"anti-tumor":[19,101],"T-cell":[20,57,95,151,348,464,496,504,512,536,558],"response":[21,211],"capable":[22,294],"rejecting":[24],"a":[25,35,48,172,193,313,341,347,367,379,395,452,457,554,647],"patient's":[26],"tumor.":[27],"Another":[28],"approach":[29],"is":[30,222,262,293,499,525,578],"activate":[32],"expand":[34],"population":[36],"autologous":[38],"tumor-reactive":[39,314],"T-cells":[40,144,619,634],"vitro":[42,73],"administer":[44,336],"them":[45],"back":[46],"patient":[49,354],"who":[50,169],"has":[51,118,289,318,399,482],"optimally":[53],"prepared":[54],"support":[56],"survival":[58],"function.":[60],"This":[61,287,422,533],"process,":[62],"adoptive":[63,661],"cell":[64,660],"therapy":[65,498,662],"(ACT),":[66],"allows":[67],"use":[69],"reagents":[71],"that":[74,89,105,132,148,225,265,291,304,402,425,584,629],"might":[75],"not":[76,275,407,500,562,585],"be":[77,91,445,600,636],"tolerated":[78],"vivo,":[80],"benefits":[82],"from":[83,352,456,495],"manipulations":[84],"(such":[85,373,382],"as":[86,374,383],"recipient":[87,133],"immunosuppression)":[88],"can":[90,269,360,430,444,587,599,635],"applied":[92],"prior":[93,206],"transfer,":[96],"avoid":[98],"damaging":[99],"response.":[102],"The":[103],"finding":[104],"tumor":[107,116,362,419,517,543],"infiltrating":[108],"lymphocytes":[109,327],"(TIL)":[110],"within":[111],"most":[112],"human":[113],"melanomas":[114],"are":[115,606,620],"reactive":[117,474],"provided":[119],"means":[121],"for":[122,150,663],"studying":[123],"ACT":[124,292,392],"cancer":[126,334],"patients.":[127,653],"Murine":[128],"models":[129],"shown":[131,290,387,401,483],"immunosuppression":[134],"removes":[135,146],"endogenous":[136],"suppressor":[137],"cells,":[138],"induces":[139],"homeostatic":[140],"proliferation":[141],"transfused":[143],"cells":[147],"compete":[149],"growth":[152],"factors.":[153],"So":[154],"protocols":[155],"transferring":[156],"cultured":[157],"TIL":[158,267,315,343,529,593,605],"(along":[159],"with":[160,166,181,215,226,301,329,366,475,488,608,638],"supportive":[161,568],"systemic":[162,569],"IL2)":[163],"into":[164],"patients":[165,197,228,252,300,311,487,589],"metastatic":[167,412],"melanoma":[168,303,429,528],"received":[171],"preparative":[173],"regimen":[174],"high-dose":[176],"cyclophosphamide":[177],"fludarabine":[179],"(Cy-Flu),":[180],"or":[182,378],"without":[183,312],"additional":[184],"total":[185],"body":[186],"irradiation":[187],"(TBI)":[188],"conducted.":[191],"In":[192,394,434,548],"group":[194],"93":[196],"(over":[198],"80%":[199],"whom":[201],"had":[202],"visceral":[203],"metastases":[204],"IL-2":[207],"treatment),":[208],"overall":[210],"rate":[212],"was":[213],"56%":[214],"21%":[216],"achieving":[217],"complete":[218,239,248,297],"responses.":[219,244],"More":[220],"striking":[221],"fact":[224],"all":[227],"having":[229],"at":[230],"least":[231],"5-year":[232],"follow":[233],"up,":[234],"19":[235],"20":[238],"responders":[240],"maintained":[242],"those":[243,337,489],"There":[245,261],"were":[246],"10":[247],"responses":[249,298,598],"25":[251],"given":[253,390,607],"Cy-Flu":[254],"highest":[257],"dose":[258],"TBI.":[260],"mounting":[263],"evidence":[264],"administered":[268],"contain":[270],"multiple":[271],"specificities,":[272],"commonly":[273],"recognizing":[274],"only":[276,408,586],"proteins":[277],"pigment":[280],"production":[281],"pathway,":[282],"but":[283,414,506,596],"also":[284,415],"tumor-specific":[285],"mutations.":[286],"experience":[288],"inducing":[296],"disseminated":[302],"appear":[305],"curative":[308],"potential.":[309],"For":[310],"population,":[316],"it":[317,398],"proven":[319],"possible":[320],"genetically":[322],"engineer":[323,527],"their":[324,333],"peripheral":[325],"blood":[326],"(PBL)":[328],"receptors":[330,449],"which":[331,443],"recognize":[332],"lieu":[339],"native":[342],"population.":[344],"Retrovirally":[345],"inserting":[346],"receptor":[349],"(TCR)":[350],"cloned":[351],"another":[353],"(sharing":[355],"appropriate":[357],"HLA":[358],"allele)":[359],"confer":[361],"recognition.":[363],"PBL":[364,404],"modified":[365],"TCR":[368],"against":[369,405,411],"melanocytic":[370],"lineage":[371],"antigens":[372,381],"MART-1":[375],"gp100)":[377],"tumor-testis":[380],"NY-ESO-1)":[384],"both":[386],"efficacy":[388,559],"when":[389,591,602],"protocols.":[393],"critical":[396],"advance,":[397],"TCR-engineered":[403],"NY-ESO-1":[406,417],"activity":[410,484],"melanoma,":[413],"positive":[418],"synovial":[420],"sarcoma.":[421],"conclusively":[423],"showed":[424],"tumors":[426,442],"other":[427,615],"than":[428],"respond":[431,590],"ACT.":[433],"order":[435],"further":[437],"broaden":[438],"scope":[440],"treated,":[446],"chimeric":[447],"antigen":[448,544],"consisting":[450],"binding":[453],"domain":[454],"derived":[455],"single":[458],"chain":[459],"immunoglobulin":[460],"coupled":[461],"transduction":[465],"moiety":[466],"CD3-zeta":[467],"developed.":[470],"One":[471,519],"such":[472,520],"receptor,":[473],"CD19":[476],"on":[477,676],"follicular":[478],"lymphomas":[479],"CLL,":[481],"refractory":[486],"diseases.":[490],"Ultimately,":[491],"real":[493],"promise":[494,628],"gene":[497,639],"merely":[502],"redirecting":[503],"specificity,":[505],"intelligent":[509],"modification":[510],"functions":[513],"better":[515],"effect":[516],"rejection.":[518],"example":[521],"clinical":[523],"testing":[524,575],"secrete":[531],"IL-12.":[532],"cytokine":[534],"enhances":[535],"secretion":[537],"gamma":[539],"interferon":[540],"augments":[542],"presentation":[545],"T-cells.":[547],"murine":[549],"models,":[550],"this":[551,576],"results":[552,582],"100-fold":[555],"increase":[556],"does":[561],"require":[563],"concomitant":[565],"administration":[566],"IL2.":[570],"phase":[572],"I/II":[573],"protocol":[574],"concept":[577],"underway":[579],"early":[581],"suggest":[583],"some":[588],"unmodified":[592],"failed,":[595],"objective":[597],"seen":[601],"many":[603],"fewer":[604],"no":[609],"accompanying":[610],"IL-2.":[611],"host":[613],"functional":[616],"modifications":[617],"currently":[621],"under":[622],"study":[623],"hold":[625],"out":[626],"carefully":[630],"crafted":[631],"populations":[632],"constructed":[637],"engineering":[640],"induce":[642],"durable":[644],"rejection":[645],"advanced":[650],"cancers":[651],"Citation":[654],"Format:":[655],"James":[656],"C.":[657],"Yang.":[658],"T":[659],"cancer:":[664],"Translating":[665],"science.":[667],"[abstract].":[668],"In:":[669],"Proceedings":[670],"AACR":[673],"Special":[674],"Conference":[675],"Tumor":[677],"Immunology:":[678],"Multidisciplinary":[679],"Science":[680],"Driving":[681],"Basic":[682],"Clinical":[684],"Advances;":[685],"Dec":[686],"2-5,":[687],"2012;":[688],"Miami,":[689],"FL.":[690],"Philadelphia":[691],"(PA):":[692],"AACR;":[693],"Cancer":[694],"Res":[695],"2013;73(1":[696],"Suppl):Abstract":[697],"nr":[698],"IA18.":[699]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}